MedTrace Logo

Ketamine IV Classic Protocol : Five Years Follow up

NCT04824157 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2021-04-01

No results posted yet for this study

Summary

Patients who suffer from MDD recieved ketamnie (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.

Conditions

Interventions

OTHER

Non

Follow up

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-08
Primary Completion
2020-02-28
Completion
2020-03-30

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04824157 on ClinicalTrials.gov